Agilon Health (AGL) Return on Capital Employed (2021 - 2026)

Agilon Health has reported Return on Capital Employed for 6 years, with the latest figure at 377.52% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed fell 31058.0% year-over-year to 377.52%; the trailing twelve-month figure through Mar 2026 stood at 377.52% (down 31058.0% YoY), and the FY2025 full-year result was 108.7%, down 5880.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 377.52%, down from 129.66% in the prior quarter.
• The five-year high for Return on Capital Employed was 6.47% in Q3 2022, with the low at 377.52% in Q1 2026.
• Historically, Return on Capital Employed has averaged 59.28% across 5 years, with a median of 32.5% in 2022.
• Annual changes were most pronounced in 2022 — Return on Capital Employed surged 3690 bps — and 2026, when it tumbled 31058 bps.
• Agilon Health's Return on Capital Employed stood at 8.44% in 2022, then tumbled by 166 bps to 22.49% in 2023, then sank by 71 bps to 38.4% in 2024, then plunged by 238 bps to 129.66% in 2025, then sank by 191 bps to 377.52% in 2026.
• The last three Return on Capital Employed figures came in at 377.52% (Q1 2026), 129.66% (Q4 2025), and 91.03% (Q3 2025), per Business Quant data.